You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API HISTRELIN ACETATE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing HISTRELIN ACETATE

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	2-HYDROXYETHYL METHACRYLATE	2026-06-16
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	DI-(4-TERT-BUTYLCYCLOHEXYL)PEROXYDICARBONATE	2026-06-16
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	METHYL BENZOIN	2026-06-16
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	OCTOXYNOL 9	2026-06-16
ENDO USA Inc	SUPPRELIN	histrelin acetate	67979-002	STEARIC ACID	2026-06-16
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for HISTRELIN ACETATE

Excipient focus: 2-HYDROXYETHYL METHACRYLATE

HISTRELIN ACETATE drug variants containing 2-HYDROXYETHYL METHACRYLATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing 2-HYDROXYETHYL METHACRYLATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: DI-(4-TERT-BUTYLCYCLOHEXYL)PEROXYDICARBONATE

HISTRELIN ACETATE drug variants containing DI-(4-TERT-BUTYLCYCLOHEXYL)PEROXYDICARBONATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing DI-(4-TERT-BUTYLCYCLOHEXYL)PEROXYDICARBONATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYL BENZOIN

HISTRELIN ACETATE drug variants containing METHYL BENZOIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing METHYL BENZOIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: OCTOXYNOL 9

HISTRELIN ACETATE drug variants containing OCTOXYNOL 9

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing OCTOXYNOL 9

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STEARIC ACID

HISTRELIN ACETATE drug variants containing STEARIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing STEARIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

Excipient focus: TRIMETHYLOLPROPANE

HISTRELIN ACETATE drug variants containing TRIMETHYLOLPROPANE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Endo Pharmaceuticals Inc	histrelin acetate	67979-500
>Company	>Ingredient	>NDC

HISTRELIN ACETATE drug variants not containing TRIMETHYLOLPROPANE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
ENDO USA Inc	histrelin acetate	67979-002
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.